[go: up one dir, main page]

EP1328151A4 - ISOLATED NUCLEIC ACIDS OF THE P-HYDE FAMILY, P-HYDE PROTEINS AND METHOD FOR PRODUCING SENSITIVITY TO THE INDUCTION OF CELL DEATH IN CANCER - Google Patents

ISOLATED NUCLEIC ACIDS OF THE P-HYDE FAMILY, P-HYDE PROTEINS AND METHOD FOR PRODUCING SENSITIVITY TO THE INDUCTION OF CELL DEATH IN CANCER

Info

Publication number
EP1328151A4
EP1328151A4 EP00953630A EP00953630A EP1328151A4 EP 1328151 A4 EP1328151 A4 EP 1328151A4 EP 00953630 A EP00953630 A EP 00953630A EP 00953630 A EP00953630 A EP 00953630A EP 1328151 A4 EP1328151 A4 EP 1328151A4
Authority
EP
European Patent Office
Prior art keywords
hyde
cancer
proteins
induction
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00953630A
Other languages
German (de)
French (fr)
Other versions
EP1328151A2 (en
Inventor
Mitchell S Steiner
Chiang Wang
Augustinus Rinaldy
Rema Menon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/499,817 external-priority patent/US7043009B1/en
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of EP1328151A2 publication Critical patent/EP1328151A2/en
Publication of EP1328151A4 publication Critical patent/EP1328151A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP00953630A 1999-04-29 2000-05-01 ISOLATED NUCLEIC ACIDS OF THE P-HYDE FAMILY, P-HYDE PROTEINS AND METHOD FOR PRODUCING SENSITIVITY TO THE INDUCTION OF CELL DEATH IN CANCER Withdrawn EP1328151A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US30245799A 1999-04-29 1999-04-29
US13160799P 1999-04-29 1999-04-29
US131607P 1999-04-29
US302457 1999-04-29
US09/499,817 US7043009B1 (en) 2000-02-08 2000-02-08 Providing customer data to an automatic call distribution system agent
US499817 2000-02-08
PCT/US2000/011456 WO2000071564A2 (en) 1999-04-29 2000-05-01 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Publications (2)

Publication Number Publication Date
EP1328151A2 EP1328151A2 (en) 2003-07-23
EP1328151A4 true EP1328151A4 (en) 2004-06-16

Family

ID=27384176

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00953630A Withdrawn EP1328151A4 (en) 1999-04-29 2000-05-01 ISOLATED NUCLEIC ACIDS OF THE P-HYDE FAMILY, P-HYDE PROTEINS AND METHOD FOR PRODUCING SENSITIVITY TO THE INDUCTION OF CELL DEATH IN CANCER

Country Status (5)

Country Link
EP (1) EP1328151A4 (en)
JP (1) JP2003529321A (en)
AU (1) AU769889B2 (en)
CA (1) CA2371828A1 (en)
WO (1) WO2000071564A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835812B1 (en) 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins
JP7716984B2 (en) * 2019-03-05 2025-08-01 ダウ グローバル テクノロジーズ エルエルシー Induction of caspase activity
CN113106082B (en) * 2021-05-27 2022-11-04 云南师范大学 Animal waste metagenome-derived alanine racemase and preparation and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001059127A2 (en) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2001072962A2 (en) * 2000-03-24 2001-10-04 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022695A2 (en) * 1995-12-20 1997-06-26 Fondation Jean Dausset-Ceph Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001059127A2 (en) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2001072962A2 (en) * 2000-03-24 2001-10-04 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMSON R B ET AL: "ISOLATION OF 10 DIFFERENTIALLY EXPRESSED CNDAS IN P53-INDUCED APOPTOSIS: ACTIVATION OF THE VERTEBRATE HOMOLOGUE OF THE DROSOPHILA SEVEN IN ABSENTIA GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 3953 - 3957, XP002032914, ISSN: 0027-8424 *
DATABASE EMBL [online] EBI; 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10829 fis, clone NT2RP4001138", XP002276044, retrieved from EMBL Database accession no. AK001691 *
JOHNSON M.I.; HAMDY F.C.: "Apoptosis regulating genes in prostate cancer (Review)", ONCOLOGY REPORTS, vol. 5, no. 3, May 1998 (1998-05-01), pages 553 - 557, XP009028911 *
RINALDY A R ET AL: "Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.", GAN TO KAGAKU RYOHO. CANCER & CHEMOTHERAPY. JAPAN MAY 2000, vol. 27 Suppl 2, May 2000 (2000-05-01), pages 215 - 222, XP009028708, ISSN: 0385-0684 *
STEINER M S ET AL: "GROWTH INHIBITION OF PROSTATE CANCER BY AN ADENOVIRUS EXPRESSING A NOVEL TUMOR SUPPRESSOR GENE, PHYDE", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 60, no. 16, 15 August 2000 (2000-08-15), pages 4419 - 4425, XP001076638, ISSN: 0008-5472 *
ZHANG X ET AL: "APOPTOSIS INDUCTION IN PROSTATE CANCER CELLS BY A NOVEL GENE PRODUCT, PHYDE, INVOLVES CASPASE-3", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 20, no. 42, 20 September 2001 (2001-09-20), pages 5982 - 5990, XP008003138, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
AU6604600A (en) 2000-12-12
WO2000071564A3 (en) 2003-05-01
AU769889B2 (en) 2004-02-05
CA2371828A1 (en) 2000-11-30
EP1328151A2 (en) 2003-07-23
WO2000071564A2 (en) 2000-11-30
WO2000071564A8 (en) 2001-10-04
JP2003529321A (en) 2003-10-07

Similar Documents

Publication Publication Date Title
DE69943292D1 (en) Process for the amplification and sequencing of nucleic acids and for the production of nucleic acids with reduced thermodynamic stability
DE60032226D1 (en) METHOD FOR THE INDUCTION OF CANCER CELL AND TUMOR REGRESSION
DE69928683D1 (en) PROCESS FOR THE AMPLIFICATION AND SEQUENCING OF NUCLEIC ACIDS
DE59912604D1 (en) PROCESS FOR THE ISOLATION AND PURIFICATION OF NUCLEIC ACIDS
DE69942659D1 (en) Process for the preparation and use of transparent heat-resistant resins
DE69736598D1 (en) Ribonucleic acid RNA preparation and its use
DE69837041D1 (en) METHOD AND MICROORGANISM FOR THE PRODUCTION OF PURIN NUCLEOSIDES BY FERMENTATION
ATE499153T1 (en) METHOD FOR PRE-HYDROLYSIS OF BIOMASS
DE60002793D1 (en) Process for the production of acrolein and acrylic acid
DE19980848D2 (en) Process for the detection of microorganisms in products
DE69929310D1 (en) TUMOR ASSOCIATED ANTIGEN DERIVATIVES OF THE MAGE FAMILY, NUCLEIC ACID SEQUENCES THAT CODE FOR THE PREPARATION OF FUSION PROTEINS AND COMPOSITIONS FOR VACCINATION
DE10084502T1 (en) Process for the purification of nucleic acid with silicon carbide
DE69132843D1 (en) Identification of nucleic acids in samples
DE60132937D1 (en) Process for the preparation of benzimidazol-2-yl quinolinone derivatives
DE60144083D1 (en) Process for the preparation of basic amino acids
PT88425A (en) DNA SEQUENCES RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING SOLUBLE T4 PROTEINS
DE60012549D1 (en) METHOD FOR ISOLATING NUCLEIC ACIDS AND KIT
DE60107987D1 (en) Process for the preparation of acrolein and acrylic acid
DE60044694D1 (en) Method for the determination of cholesterol and sensor therefor
DE60125747D1 (en) PROCESS FOR THE PREPARATION OF 2-HALOBENZOIC ACIDS
DE60033825D1 (en) DETECTION OF DIFFERENCES IN NUCLEIC ACIDS BY INHIBITION OF SPONTANEOUS DNA BRANCHING MIGRATION
DE50207915D1 (en) Process for the preparation of bisallylboranes and non-aromatic boronic acids
DE59915087D1 (en) METHOD OF CONTROLLING DAMAGE TO THE CULTURE OF BT-COTTON
DE50010521D1 (en) PROCESS FOR COLD PRODUCTION OF PEN GLOSSY TENSID PREPARATIONS
DE69909181D1 (en) Process for the production of acrolein and acrylic acid

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011112

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/861 B

Ipc: 7A 61K 31/7052 B

Ipc: 7C 12Q 1/70 B

Ipc: 7G 01N 33/574 B

Ipc: 7C 07K 16/30 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 B

Ipc: 7A 01K 67/027 B

Ipc: 7C 12P 21/00 B

Ipc: 7A 61P 35/00 B

Ipc: 7C 07K 19/00 B

Ipc: 7C 07K 16/00 B

Ipc: 7A 61K 48/00 B

Ipc: 7C 07H 21/00 B

Ipc: 7C 12N 15/62 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040504

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080411